U.S. markets close in 2 hours 2 minutes

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
39.04-0.66 (-1.66%)
As of 1:58PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/26/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
24.49B26.48B30.39B25.54B29.47B
Enterprise Value 3
27.94B29.65B33.47B28.11B33.74B
Trailing P/E
46.0633.0528.5836.4020.29
Forward P/E 1
15.1316.3718.2515.29N/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
11.167.7215.1313.219.15
Price/Book (mrq)
5.025.506.836.145.71
Enterprise Value/Revenue 3
12.7351.7458.4952.2166.03
Enterprise Value/EBITDA 7
14.58146.7381.5742.5052.56

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-5.32%
S&P500 52-Week Change 337.41%
52 Week High 353.23
52 Week Low 334.80
50-Day Moving Average 342.52
200-Day Moving Average 344.36

Share Statistics

Avg Vol (3 month) 31.95M
Avg Vol (10 day) 31.3M
Shares Outstanding 5427.01M
Implied Shares Outstanding 6607.17M
Float 306.32M
% Held by Insiders 116.41%
% Held by Institutions 162.83%
Shares Short (Jun 29, 2021) 49.36M
Short Ratio (Jun 29, 2021) 43.9
Short % of Float (Jun 29, 2021) 43.38%
Short % of Shares Outstanding (Jun 29, 2021) 41.54%
Shares Short (prior month May 27, 2021) 415.91M

Dividends & Splits

Forward Annual Dividend Rate 40.68
Forward Annual Dividend Yield 41.69%
Trailing Annual Dividend Rate 30.47
Trailing Annual Dividend Yield 31.18%
5 Year Average Dividend Yield 4N/A
Payout Ratio 453.67%
Dividend Date 3Sep 14, 2021
Ex-Dividend Date 4Aug 18, 2021
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 44.33%
Operating Margin (ttm)69.64%

Management Effectiveness

Return on Assets (ttm)6.52%
Return on Equity (ttm)20.61%

Income Statement

Revenue (ttm)2.19B
Revenue Per Share (ttm)5.71
Quarterly Revenue Growth (yoy)14.40%
Gross Profit (ttm)1.89B
EBITDA 1.55B
Net Income Avi to Common (ttm)493.08M
Diluted EPS (ttm)1.21
Quarterly Earnings Growth (yoy)-3.00%

Balance Sheet

Total Cash (mrq)1.85B
Total Cash Per Share (mrq)4.7
Total Debt (mrq)5.82B
Total Debt/Equity (mrq)59.17
Current Ratio (mrq)9.44
Book Value Per Share (mrq)12.43

Cash Flow Statement

Operating Cash Flow (ttm)2.09B
Levered Free Cash Flow (ttm)-1.72B